Participants
| Role | Name | HCID | Charge |
|---|
| Reactant | Rosuvastatin | HCID 446157 | — |
| Reactant | Calcium chloride, dihydrate | HCID 6093260 | — |
| Solvent | Water | HCID 962 | — |
| Product | Rosuvastatin | HCID 446157 | — |
| Product | Calcium | HCID 5460341 | — |
Reaction Steps
(E)-7-[4-(4-Fluorophenyl)-6-isopropyl-2-[methyl(methylsulfonyl)amino]pyrimidin-5-yl](3R,5S)-3,5-dihydroxyhept-6-enoic acid TRIS salt (17.7 g) was dissolved in degassed water (120 ml) at 20° C. then the solution was heated to 40° C. A solution of calcium chloride dihydrate (2.6 g) in water (25 ml) was added dropwise at about 40° C. over 20 minutes. The mixture was stirred for 15 minutes, allowed to cool to 20° C. over 60 minutes, held at this temperature for a further 60 minutes and the resultant solid filtered. The solid was washed with water (140 ml) and dried under a flow of nitrogen to give non-crystalline calcium salt of (E)-7-[4-(4-fluorophenyl)-6-isopropyl-2-[methyl(methylsulfonyl)amino]pyrimidin-5-yl](3R,5S)-3,5-dihydroxyhept-6enoic acid.
Provenance & Evidence
| DOI | 10.6084/m9.figshare.5104873.v1 |
|---|
| Patent number | US07511140B2 |
|---|
| Source dataset | uspto-grants-2009_03 |
|---|
| ORD ID | ord-7f99a04f97a2475d97364648a410fee6 |
|---|
| Source note | uspto-grants-2009_03 |
|---|